|
⚲
|
| Keyboard |
| Schiermeier Andrew
✚
|
|
|---|---|
| CIK # | 0001738456 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001738456] | |
| 4 | [0001738456] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Intellia Therapeutics Inc | |
| Schiermeier Andrew |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2021-03-03 | Grant | 78,750 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Restricted Stock Unit · derivative
|
2021-03-03 | Grant | 13,125 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2021-01-05 | Sell | 1,377 | $55.86 | 76,919 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2020-12-31 | Option exercise | 4,792 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Restricted Stock Unit (performance-based) · derivative
|
2020-12-31 | Grant | 4,792 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Restricted Stock Unit (performance-based) · derivative
|
2020-12-31 | Option exercise | 4,792 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2020-12-31 | Grant | 9,583 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2020-12-30 | Option exercise | 1,500 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2020-12-30 | Option exercise | 1,500 | $13.48 | 20,220 |
|
Intellia Therapeutics Inc NTLA
Stock Option (Right to Buy) · derivative
|
2020-03-02 | Grant | 135,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (Right to Buy) · derivative
|
2020-01-03 | Grant | 15,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (Right to Buy) · derivative
|
2019-08-01 | Grant | 55,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2019-03-06 | Buy | 3,250 | $16.00 | 52,000 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2019-03-06 | Buy | 4,250 | $15.50 | 65,875 |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2018-12-18 | Grant | 81,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2018-05-01 | Grant | 23,500 | $0.00 |